Lilly’s Bet on Abridge Exposes the Recruitment Handoff Nobody Wants to Own
Eli Lilly invested in Abridge's AI recruitment tool — but the real question is whether sites can operationalize patient...
Sponsor-Site Operations
Eli Lilly invested in Abridge's AI recruitment tool — but the real question is whether sites can operationalize patient...